Classification
Product TypeIngredient
Product FormPowder (bulk dietary ingredient/API)
Industry PositionMicronutrient (vitamin B12) ingredient used in dietary supplements and food fortification
Market
Cyanocobalamin (vitamin B12) in the United States is primarily a regulated B2B ingredient market serving dietary supplement manufacturing and, secondarily, food fortification and certain pharmaceutical uses. The U.S. market is compliance-driven: buyers typically require robust identity/potency specifications, lot-level documentation, and supplier qualification consistent with FDA expectations for dietary supplement quality systems. Supply is generally inventory- and import-channel driven rather than seasonal, and disruptions most often arise from regulatory enforcement actions, testing failures, or documentation gaps. Distribution commonly runs through specialized nutraceutical ingredient distributors and contract manufacturers rather than direct-to-consumer retail.
Market RoleImport-dependent consumer and manufacturing market (dietary supplements and fortification)
Domestic RoleKey downstream manufacturing and consumption market for vitamin B12-containing supplements and fortified products
Market GrowthNot Mentioned
SeasonalityNon-seasonal; industrial production and inventory management drive availability rather than harvest cycles.
Specification
Physical Attributes- Light-sensitive vitamin ingredient; requires light-protective handling through storage and distribution
- Typically supplied as a dry solid suitable for blending into premixes and finished supplement forms
Compositional Metrics- Identity confirmation (vitamin B12/cyanocobalamin identification testing)
- Potency/assay against specification and label-claim needs for downstream products
- Impurity profile controls (buyer- and application-specific)
Grades- Buyer-specified grade aligned to intended use (dietary supplement vs food-use vs pharmaceutical-use specifications)
Packaging- Moisture- and light-barrier packaging (e.g., sealed inner liner within an outer drum/carton) to protect potency and stability in U.S. distribution
Supply Chain
Value Chain- Upstream production (specialized industrial synthesis/bioprocess) → purification/drying → bulk packaging → importer/distributor qualification → incoming QC testing → blending/premix → finished supplement/fortified food manufacturing
Temperature- Ambient distribution is typical, but protect from excessive heat and humidity to preserve potency
Atmosphere Control- Protect from light exposure during storage and handling; keep containers closed to limit moisture uptake
Shelf Life- Stability is strongly dependent on protection from light, heat, and moisture; mishandling can translate into potency loss and out-of-spec results at receiving QC
Freight IntensityLow
Transport ModeMultimodal
Risks
Regulatory Compliance HighU.S. FDA enforcement actions (e.g., import detention/refusal or extended holds) triggered by cGMP concerns, identity/potency failures, or documentation mismatches can abruptly block or delay cyanocobalamin ingredient entry and disrupt downstream supplement manufacturing schedules.Use audited suppliers with strong quality agreements; verify lot identity/potency with risk-based third-party testing; run pre-shipment document reconciliation (labels, CoA, lot codes) and maintain alternate qualified sources.
Product Quality MediumPotency loss or out-of-spec results can occur when the ingredient is exposed to light, heat, or moisture during storage and transit, causing receiving QC failures and potential production downtime.Specify light- and moisture-barrier packaging; enforce storage/handling SOPs; require stability-related handling statements and verify packaging integrity at receipt.
Documentation Gap MediumIncomplete or inconsistent supplier documentation (CoA parameters, test methods, traceability, change notifications) can fail U.S. buyer qualification requirements even when the material is chemically acceptable.Standardize a supplier document checklist (CoA format, methods, traceability, change control) and integrate it into purchasing release gates.
Counterfeit Risk MediumEconomically motivated adulteration or misrepresentation (substitution, dilution, or mislabeled potency) is a recognized risk for high-compliance dietary supplement inputs and can trigger recalls or regulatory action in the U.S. market.Buy only from qualified suppliers; require method-validated identity testing and periodic full compendial-style verification by independent laboratories.
Logistics LowWhile freight cost is generally not the primary driver, shipment delays and poor packaging/handling (light/moisture exposure) can lead to quality failures or missed production windows.Use tamper-evident, light-protective packaging; set clear handling instructions; and pre-book contingency lead times for FDA holds.
Sustainability- Supplier environmental compliance expectations for industrial vitamin production (e.g., wastewater/solvent/chemical management) may be part of U.S. buyer ESG and audit programs
Labor & Social- Strong buyer emphasis on audited quality systems and ethical sourcing documentation for imported inputs, including screening for forced-labor compliance risks where relevant to upstream supply chains
Standards- NSF/ANSI 173 (dietary supplements)
- ISO 9001
- ISO 22000 or FSSC 22000 (when suppliers align to food safety management systems)
FAQ
What is the biggest U.S. market-access risk when importing cyanocobalamin for supplements?The most critical risk is U.S. FDA compliance action at entry (holds, detention, or refusal) triggered by cGMP concerns, identity/potency failures, or documentation mismatches. This can delay or block supply to U.S. manufacturers, so buyers typically mitigate it with audited suppliers, quality agreements, and risk-based third-party testing.
Why do U.S. buyers emphasize light-protective packaging for cyanocobalamin?Because cyanocobalamin is light-sensitive, exposure during storage or transit can contribute to potency loss and receiving QC failures. U.S. buyer programs often require moisture- and light-barrier packaging plus handling controls to reduce out-of-spec risk.
Which documents are commonly expected by U.S. buyers for cyanocobalamin lots?Common expectations include a lot-specific Certificate of Analysis (CoA), a specification sheet, an SDS, and traceability records tied to the lot/batch. These support supplier qualification and receiving QC controls aligned with U.S. dietary supplement quality system expectations.